Abstract
Pancreatic stellate cells (PSC) play a key role in pancreatic fibrosis. Activation of PSC occurs in response to pro-fibrogenic stimuli and is maintained by autocrine loops of mediators, such as endothelin (ET)-1. Here, we have evaluated effects of the dual ET receptor antagonist bosentan in models of pancreatic fibrogenesis and cancer. Cell culture studies revealed that PSC and DSL6A pancreatic cancer cells expressed both ET-1 and ET receptors. Bosentan efficiently inhibited proliferation of both cell types and collagen synthesis in PSC. Expression of the myofibroblastic marker α-smooth muscle actin, connective tissue growth factor, and ET-1 itself in PSC was reduced, while expression of matrix metalloproteinase-9 was enhanced. Like PSC, DSL6A cells secrete less ET-1 when cultured with bosentan. In a rat model of pancreatic fibrosis, chronic pancreatitis induced by dibutyltin dichloride, a tendency towards a diminished disease progression was observed in a subgroup of rats with less severe disease. Together, our results indicate that bosentan exerts antifibrotic and antitumor effects in vitro. Its efficiency in vivo warrants further investigation.
Similar content being viewed by others
References
Longnecker DS (1982) Pathology and pathogenesis of diseases of the pancreas. Am J Pathol 107:99–121
Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK et al (2004) Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29:179–187. doi:10.1097/00006676-200410000-00002
Kuniyasu H, Abbruzzese JL, Cleary KR, Fidler IJ (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685
Lohr M, Schmidt C, Ringel J, Kluth M, Müller P, Nizze H et al (2001) Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res 61:550–555
Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A et al (2005) Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128:907–921. doi:10.1053/j.gastro.2004.12.036
Witt H, Apte MV, Keim V, Wilson JS (2007) Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132:1557–1573. doi:10.1053/j.gastro.2007.03.001
Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR et al (2004) Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10:7427–7437. doi:10.1158/1078-0432.CCR-03-0825
Qian LW, Mizumoto K, Maehara N, Ohuchida K, Inadome N, Saimura M et al (2003) Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett 190:105–112. doi:10.1016/S0304-3835(02)00517-7
Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E et al (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64:3215–3222. doi:10.1158/0008-5472.CAN-03-2464
Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S (2004) Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 28:38–44. doi:10.1097/00006676-200401000-00006
Köninger J, Giese NA, di Mola FF, Berberat P, Giese T, Esposito I et al (2004) Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. Clin Cancer Res 10:4776–4783. doi:10.1158/1078-0432.CCR-1190-03
Müerköster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse ML et al (2004) Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64:1331–1337. doi:10.1158/0008-5472.CAN-03-1860
Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA et al (1998) Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43:128–133
Bachem MG, Schneider E, Groß H, Weidenbach H, Schmid RM, Menke A et al (1998) Identification, culture, and characterisation of pancreatic stellate cells in rats and humans. Gastroenterology 115:421–432. doi:10.1016/S0016-5085(98)70209-4
Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA et al (1999) Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44:534–541
Apte MV, Phillips PA, Fahmy RG, Darby SJ, Rodgers SC, McCaughan GW et al (2000) Does alcohol directly stimulate pancreatic fibrogenesis? Gastroenterology 118:780–794. doi:10.1016/S0016-5085(00)70148-X
Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G et al (2000) Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 80:47–55
Kruse ML, Hildebrand PB, Timke C, Fölsch UR, Schmidt WE (2000) TGFβ1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro. Regul Pept 90:47–52. doi:10.1016/S0167-0115(00)00104-X
Klonowski-Stumpe H, Reinehr R, Fischer R, Warskulat U, Luthen R, Haussinger D (2003) Production and effects of endothelin-1 in rat pancreatic stellate cells. Pancreas 27:67–74. doi:10.1097/00006676-200307000-00010
Masamune A, Satoh M, Kikuta K, Suzuki N, Shimosegawa T (2005) Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells. World J Gastroenterol 11:6144–6151
Jaster R, Lichte P, Fitzner B, Brock P, Glass Ä, Karopka T et al (2005) Peroxisome proliferator-activated receptor γ overexpression inhibits pro-fibrogenic activities of immortalized rat pancreatic stellate cells. J Cell Mol Med 3:670–682. doi:10.1111/j.1582-4934.2005.tb00497.x
Clozel M, Salloukh H (2005) Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann Med 37:2–12. doi:10.1080/07853890410018925
Oikawa T, Kushuhara M, Ishikawa S, Hitomi J, Kono A, Iwanaga T et al (1994) Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells. Br J Cancer 69:1059–1064
Bhargava S, Stummeyer T, Hotz B, Hines OJ, Reber HA, Buhr HJ et al (2005) Selective inhibition of endothelin receptor A as an anti-angiogenic and anti-proliferative strategy for human pancreatic cancer. J Gastrointest Surg 9:703–709. doi:10.1016/j.gassur.2004.11.007
Rubin LJ, Roux S (2002) Bosentan: a dual endothelin receptor antagonist. Expert Opin Investig Drugs 11:991–1002. doi:10.1517/13543784.11.7.991
Sparmann G, Merkord J, Jäschke A, Nizze H, Jonas L, Lohr M et al (1997) Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 112:1664–1672. doi:10.1016/S0016-5085(97)70049-0
Jaster R, Sparmann G, Emmrich J, Liebe S (2002) Extracellular signal-regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 51:579–584. doi:10.1136/gut.51.4.579
Jaster R, Hilgendorf I, Fitzner B, Brock P, Sparmann G, Emmrich J et al (2003) Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid. Biochem Pharmacol 66:633–641. doi:10.1016/S0006-2952(03)00390-3
Fitzner B, Walzel H, Sparmann G, Emmrich J, Liebe S, Jaster R (2005) Galectin-1 is an inductor of pancreatic stellate cell activation. Cell Signal 17:1240–1247. doi:10.1016/j.cellsig.2004.12.012
Brock P, Sparmann G, Ritter T, Jaster R, Liebe S, Emmrich J (2005) Interleukin-4 gene transfer into rat pancreas by recombinant adenovirus. Scand J Gastroenterol 40:1109–1117. doi:10.1080/00365520510023404
Merkord J, Jonas L, Weber H, Kroning G, Nizze H, Hennighausen G (1997) Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas 15:392–401. doi:10.1097/00006676-199711000-00010
Merkord J, Weber H, Sparmann G, Jonas L, Hennighausen G (1999) The course of pancreatic fibrosis induced by dibutyltin dichloride (DBTC). Ann N Y Acad Sci 880:231–237. doi:10.1111/j.1749-6632.1999.tb09527.x
Park SH, Saleh D, Giaid A, Michel RP (1997) Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med 156:600–608
Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG et al (2000) An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 118:1169–1178. doi:10.1016/S0016-5085(00)70370-2
Hocher B, Schwarz A, Fagan KA, Thöne-Reineke C, El-Hag K, Kusserow H et al (2000) Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 23:19–26
Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15:290–301. doi:10.1007/s004670000461
Ramires FJ, Nunes VL, Fernandes F, Mady C, Ramires JA (2003) Endothelins and myocardial fibrosis. J Card Fail 9:232–237. doi:10.1054/jcaf.2003.26
Gressner AM, Bachem MG (1995) Molecular mechanisms of liver fibrogenesis—a homage to the role of activated fat-storing cells. Digestion 56:335–346
Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH et al (1999) Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 155:1087–1095
Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816–827. doi:10.1096/fj.03-1273rev
Sihvola RK, Pulkkinen VP, Koskinen PK, Lemström KB (2002) Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis. J Am Coll Cardiol 39:710–717. doi:10.1016/S0735-1097(01)01782-X
Hafizi S, Allen SP, Goodwin AT, Chester AH, Yacoub MH (1999) Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors. Atherosclerosis 146:351–359. doi:10.1016/S0021-9150(99)00178-1
Kunichika N, Landsberg JW, Yu Y, Kunichika H, Thistlethwaite PA, Rubin LJ et al (2004) Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes. Am J Respir Crit Care Med 170:1101–1107. doi:10.1164/rccm.200312-1668OC
Fiedler F, Ayasse D, Rohmeiss P, Gretz N, Rehbein C, Keim V (1999) The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats. Int J Pancreatol 26:147–154. doi:10.1385/IJGC:26:3:147
Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F et al (1997) Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96:1976–1982
Boffa JJ, Tharaux PL, Dussaule JC, Chatziantoniou C (2001) Regression of renal vascular fibrosis by endothelin receptor antagonism. Hypertension 37:490–496
Acknowledgments
We gratefully acknowledge the excellent technical assistance of Mrs. Katja Bergmann, Mrs. Helga Schulze, and Mrs. Katrin Sievert-Küchenmeister. The in vitro studies with PSC and the in vivo studies with DBTC-treated rats were supported by a grant from the Deutsche Forschungsgemeinschaft. Investigations regarding bosentan effects in pancreatic cancer cells were funded by Actelion.
Competing Interests
The following relationship could be construed as resulting in an actual, potential, or apparent conflict of interest with regard to the manuscript: The laboratory of R. Jaster has received research support from Actelion for the studies with DSL6A pancreatic cancer cells.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fitzner, B., Brock, P., Holzhüter, SA. et al. Synergistic Growth Inhibitory Effects of the Dual Endothelin-1 Receptor Antagonist Bosentan on Pancreatic Stellate and Cancer Cells. Dig Dis Sci 54, 309–320 (2009). https://doi.org/10.1007/s10620-008-0366-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0366-z